Lantheus Holdings, Inc.
Status: Publicly traded
Direct answer
Lantheus Holdings, Inc. is publicly traded on NASDAQ under the ticker LNTH.
Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagnostic portfolio...
Can you invest in Lantheus Holdings, Inc.?
Yes. Lantheus Holdings, Inc. trades publicly on NASDAQ as LNTH.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Lantheus Holdings, Inc.
Detailed equity research is provided by MarketSnap.